Hyperprolactinemic recurrent spontaneous pregnancy loss: A true clinical entity or a spurious finding?

Fertility and Sterility

Volumn 70, Issue 2, 1998, Pages 253-255

  Dlugi, Alexander M ^a  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE; PROLACTIN; PROTIRELIN; THYROID HORMONE;

CORPUS LUTEUM; HUMAN; HYPERPROLACTINEMIA; LUTEINIZING HORMONE RELEASE; NONHUMAN; OVULATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTIRELIN TEST; RECURRENT ABORTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; THYROID HORMONE RELEASE;

EID: 0032146386     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00162-9     Document Type: Editorial

References (5)

1. 1. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998;70:246-52.
2. 2. Adashi EY, Leung PCK, editors. The ovary. New York: Raven Press, 1993.
3. 3. Soules MR, Bremner WJ, Steiner RA, Clifton DK. Prolactin secretion and corpus luteum function in women with luteal phase deficiency. J Clin Endocrinol Metab 1991;986-92.
4. 4. Asukai K, Uemura T, Minaguchi H. Occult hyperprolactinemia in infertile women. Fertil Steril 1993;60:423-7.
5. 5. Buncher CR, Weiner D. Reference values. In: Kaplan LA, Pesce AJ, editors. Clinical chemistry: theory, analysis, and correlation. St. Louis: CV Mosby, 1984:301-9.